(19)
(11) EP 4 225 351 A1

(12)

(43) Date of publication:
16.08.2023 Bulletin 2023/33

(21) Application number: 21880926.7

(22) Date of filing: 12.10.2021
(51) International Patent Classification (IPC): 
A61K 38/19(2006.01)
A61K 38/21(2006.01)
A61K 39/395(2006.01)
 A61K 38/20(2006.01)
A61K 39/12(2006.01)
C07K 14/005(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/12; C12N 2710/20034; A61K 2039/876; A61K 2039/505; A61K 2039/55522; A61K 35/17; A61K 38/208; A61K 38/2086; A61K 38/212; A61K 38/193
 
C-Sets:
  1. A61K 38/193, A61K 2300/00;
  2. A61K 35/17, A61K 2300/00;
  3. A61K 38/208, A61K 2300/00;
  4. A61K 38/2086, A61K 2300/00;
  5. A61K 38/212, A61K 2300/00;
(86) International application number:
PCT/US2021/054622
(87) International publication number:
WO 2022/081604 (21.04.2022 Gazette 2022/16)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 12.10.2020 US 202017068087

(71) Applicant: HPVVAX, LLC
Port St. Lucie, FL 34986 (US)

(72) Inventors:
  • IOANNIDES, Tim
    Port St. Lucie, FL 34986 (US)
  • BADIAVAS, Evangelos, V.
    Coral Gables, FL 33146 (US)

(74) Representative: Zaccaro, Elisabetta et al
Notarbartolo & Gervasi S.p.A. Viale Achille Papa, 30
20149 Milano
20149 Milano (IT)

   


(54) COMPOSITION AND METHOD FOR TREATING CANCER USING A VACCINE AS A FIRST THERAPUEUTIC ACTIVE INGREDIENT IN COMBINATION WITH A SECOND ACTIVE INGREDIENT